Link copied to clipboard!
2022 Wrestling / Lutte Doping English Anti-doping Procedure

Parties & Representatives

Appellant Representative: Adam Klevinas
Respondent: Nathan Dyamin Jackson
Respondent Representative: Howard L. Jacobs; Lindsay Brandon

Arbitrators

President: Susan Ahern

Decision Information

Decision Date: May 13, 2022

Case Summary

The case revolves around Nathan Dyamin Jackson, an American wrestler who tested positive for boldenone, a prohibited anabolic steroid, during the 2021 Senior Pan American Championships in Guatemala. The adverse analytical finding (AAF) led to an anti-doping rule violation (ADRV) charge under the United World Wrestling (UWW) Anti-Doping Rules, which align with the World Anti-Doping Code (WADC). The dispute centered on whether the presence of boldenone in Jackson’s system resulted from intentional doping or unintentional ingestion through contaminated meat. The legal framework required UWW to prove the violation to the "comfortable satisfaction" of the hearing panel, after which the burden shifted to Jackson to demonstrate the violation was unintentional or to mitigate the sanction.

Jackson denied intentional doping and argued that the boldenone entered his system through contaminated meat consumed in Guatemala, a region known for using growth promoters in livestock. He cited scientific evidence and contextual factors, including the low concentration of boldenone in his sample and the fact that two other athletes at the same event also tested positive for similar substances. Jackson’s defense included expert testimony from Dr. Anneleen Decloedt, who highlighted studies showing boldenone use in Guatemalan livestock and the plausibility of meat contamination. However, another expert, Professor Martial Saugy, expressed skepticism, noting the difficulty of proving contamination without direct evidence and suggesting residual excretion from prior use as an alternative explanation.

The case underscored the challenges athletes face in proving unintentional ingestion, particularly when the source of contamination cannot be definitively identified. Jackson’s credibility was bolstered by his consistent testimony, anti-doping education, and the absence of prior violations. The Sole Arbitrator considered the delayed notification of the ADRV, which hindered evidence gathering, and the pattern of positive tests among athletes at the event. Ultimately, the arbitrator found Jackson’s evidence persuasive, concluding he bore no fault or negligence for the violation. As a result, no period of ineligibility was imposed, though his competitive results from the event were disqualified.

The decision highlighted the strict liability principle in anti-doping regulations, where athletes are responsible for prohibited substances in their bodies regardless of intent. It also emphasized the importance of timely proceedings and the role of contextual evidence in adjudicating contamination claims. The case illustrates the balance between enforcing anti-doping rules and ensuring fairness for athletes who may inadvertently ingest banned substances. The ruling acknowledged the complexities of such cases, where scientific and circumstantial evidence must be carefully weighed to determine the likelihood of unintentional ingestion. The outcome reinforced the need for robust anti-doping systems while recognizing the challenges posed by environmental contamination in certain regions.

Share This Case